CN1279974A - Compound red and yellow psoriasis capsule - Google Patents
Compound red and yellow psoriasis capsule Download PDFInfo
- Publication number
- CN1279974A CN1279974A CN 00111180 CN00111180A CN1279974A CN 1279974 A CN1279974 A CN 1279974A CN 00111180 CN00111180 CN 00111180 CN 00111180 A CN00111180 A CN 00111180A CN 1279974 A CN1279974 A CN 1279974A
- Authority
- CN
- China
- Prior art keywords
- gram
- capsule
- psoriasis
- radix
- compound red
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
A compound psoriasis capsule is prepared by using 14 kinds of Chinese medicinal materials including safflower, Astragalus membranacenus, Atractylodis Macrocephalae, Radix Ledebouriellae, Caulis Fibraureae, etc. Its preparation method includes the technological process of water soaking and decoction, pressure reducing-drying to producea powder, mixing the powder proper amount of vehicle, and capsulizing. The capsule is used to treat psoriasis of different forms, including ordinary form, arthritis form, pustule form and erythroderma form.
Description
The present invention relates to a kind of Chinese patent medicine, relate to a kind of psoriatic compound red and yellow psoriasis capsule that is used for the treatment of particularly.
At present, be used for the treatment of psoriatic Chinese patent medicine such as FUFANG QINGDAI WAN, Xiaoyin spirit, Etretinate electuary and December in 1996 Chinese patent CN1137413A disclosed " a kind of antipsoriatics thing--Yuxianwan " on the 11st, Chinese patent CN1230420 " psoriatic Chinese medicine preparation of a kind of treatment and preparation method thereof " etc. in 1998, be used for the treatment of psoriasis vulgaris and have certain clinical effectiveness.But, exist the scope of application to be confined to homeliness type, to the deficiency of arthritis type, pustule type, erythrodermic weak curative effect.
The objective of the invention is to overcome the deficiency of above-mentioned existence, a kind of treatment homeliness type, arthritis type, pustule type, each psoriasis pustulosa of erythrodermic of being applicable to is provided, and onset is rapid, good effect, be difficult for recurrence, the compound red and yellow psoriasis capsule of not leaded, arsenic, the poisonous element of hydrargyrum.
The objective of the invention is to improve on the basis of handed down from the older generations of the family prescription reddish yellow soup dosage form realizes.
Prescription of the present invention is as follows: Flos Carthami 100--200 gram Radix Astragali 100--200 gram Rhizoma Atractylodis Macrocephalae 80--120 gram Radix Saposhnikoviae 80--120 gram Caulis Fibraureae 100--250 gram Radix Rehmanniae 250--400 gram Cortex Moutan 100--250 gram Radix Paeoniae Alba 100--200 gram Fructus Gardeniae 70--100 gram Radix Sophorae Flavescentis 70--150 gram Radix Glycyrrhizae 60--120 gram Radix Stephaniae Tetrandrae 100--200 gram Pericarpium Citri Reticulatae 30--90 gram Radix Scrophulariae 200--300 gram
Compound red and yellow psoriasis capsule of the present invention has adopted the said medicine prescription, extracts through decocting and makes capsule, and wherein the Caulis Fibraureae heat-clearing and toxic substances removing improves spleen CAMP content and CAMP/CGMP ratio, is monarch drug; The Radix Rehmanniae, Radix Scrophulariae, removing heat from blood promote the production of body fluid, the refrigerant heart kidney of Fructus Gardeniae, and the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Radix Saposhnikoviae are the YUPINGFENG SAN composition, the energy enhancing immunity, Radix Stephaniae Tetrandrae, Flos Carthami immunity-regulating are ministerial drug altogether; Cortex Moutan, Radix Paeoniae Alba removing heat from blood and promoting blood circulation, Radix Sophorae Flavescentis, the antipruritic skin moistening of Radix Scrophulariae, Pericarpium Citri Reticulatae, Rhizoma Atractylodis Macrocephalae spleen invigorating are adjuvant drug altogether; With Caulis Fibraureae toxicity and inhibition immunity, coordinating the actions of various ingredients in a prescription is for making accessory drugs in the Radix Glycyrrhizae.All medicines share, and play heat-clearing and toxic substances removing, removing heat from blood and promoting blood circulation, and Yin-nourishing and body fluid promoting, the spleen invigorating skin moistening, debris removal is antipruritic, Yin Yang balancing; Regulate immunity, improve the effect of CAMP content and CAMP/CGMP ratio.Be applied to various psoriatic treatment and can eliminate inflammatory infiltration rapidly, suppress hyperplasia, promote that the epidermis cell keratinization is normal.
Compound red and yellow psoriasis capsule of the present invention, its prescription rationally, dosage form is suitable, onset is rapid, good effect is difficult for recurrence, not leaded, arsenic, the poisonous element of hydrargyrum.Proposition is applied to treat homeliness type, arthritis type, pustule type, each psoriasis pustulosa of erythrodermic.
The invention will be further described below in conjunction with most preferred embodiment.Get the Flos Carthami 150 gram Radixs Astragali 150 gram Rhizoma Atractylodis Macrocephalaes 100 gram Radix Saposhnikoviaes 100 gram Caulis Fibraureaes 200 gram Radix Rehmanniae 350 gram Cortex Moutans 150 gram Radix Paeoniae Albas 120 gram Fructus Gardeniaes 70 gram Radix Sophorae Flavescentiss 70 gram Radix Glycyrrhizaes 60 gram Radixs Stephaniae Tetrandrae 100 gram Pericarpium Citri Reticulataes 30 gram Radix Scrophulariaes 300 grams
Adopt decocting technology that the common water logging of above-mentioned whole medicines is fried in shallow oil and carry, 50 mesh sieves are crossed in powder process behind the drying under reduced pressure, and being supplemented to weight with excipient is 50.4 grams, and adopting capsule technology to make specification is every 0.42 gram capsule, totally 120.
Usage and consumption: 4 to 12 of every days, divide 2--3 inferior to 30 minutes after meal warm water delivery services.
Claims (3)
1, compound red and yellow psoriasis capsule is characterized in that being made up of following 14 flavor Chinese medicines: the Flos Carthami 150 gram Radixs Astragali 150 gram Rhizoma Atractylodis Macrocephalaes 100 gram Radix Saposhnikoviaes 100 gram Caulis Fibraureaes 200 gram Radix Rehmanniae 350 gram Cortex Moutans 150 gram Radix Paeoniae Albas 120 gram Fructus Gardeniaes 70 gram Radix Sophorae Flavescentiss 70 gram Radix Glycyrrhizaes 60 gram Radixs Stephaniae Tetrandrae 100 gram Pericarpium Citri Reticulataes 30 gram Radix Scrophulariaes 300 grams
2, according to the described compound red and yellow psoriasis capsule of claim 1, it is characterized in that: adopt decocting technology that the common water logging of whole medicines is fried in shallow oil and carry, drying under reduced pressure powder process, replenishing an amount of excipient to weight is 50.4 grams, adopting capsule technology to make specification is every 0.42 gram capsule.
3, it is characterized in that according to claim 1,2 described compound red and yellow psoriasis capsules: be used for the treatment of homeliness type, arthritis type, pustule type, each psoriasis pustulosa of erythrodermic.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN00111180A CN1113662C (en) | 2000-07-10 | 2000-07-10 | Compound red and yellow psoriasis capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN00111180A CN1113662C (en) | 2000-07-10 | 2000-07-10 | Compound red and yellow psoriasis capsule |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1279974A true CN1279974A (en) | 2001-01-17 |
CN1113662C CN1113662C (en) | 2003-07-09 |
Family
ID=4581113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN00111180A Expired - Fee Related CN1113662C (en) | 2000-07-10 | 2000-07-10 | Compound red and yellow psoriasis capsule |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1113662C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102688318A (en) * | 2012-04-19 | 2012-09-26 | 田杰 | Traditional Chinese medicine composition for treating segmental vitiligo |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1162472A (en) * | 1996-04-18 | 1997-10-22 | 冯程 | Medicine for psoriasis |
CN1056531C (en) * | 1997-08-29 | 2000-09-20 | 刘进成 | Chinese medicinal herb composition for treating skin disease |
CN1212872A (en) * | 1997-09-26 | 1999-04-07 | 湖北蒲纺集团医院 | Chinese patent drug for treating psoriasis |
CN1060953C (en) * | 1998-01-22 | 2001-01-24 | 李卓伦 | Medicine for curing psoriasis |
CN1242201A (en) * | 1998-07-20 | 2000-01-26 | 徐景信 | Patent traditional Chinese medicine for treating psoriasis, and method for preparing same |
CN1063967C (en) * | 1998-10-21 | 2001-04-04 | 余际康 | Oral medicine for curing dermatosis |
-
2000
- 2000-07-10 CN CN00111180A patent/CN1113662C/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102688318A (en) * | 2012-04-19 | 2012-09-26 | 田杰 | Traditional Chinese medicine composition for treating segmental vitiligo |
CN102688318B (en) * | 2012-04-19 | 2013-08-21 | 田杰 | Traditional Chinese medicine composition for treating segmental vitiligo |
Also Published As
Publication number | Publication date |
---|---|
CN1113662C (en) | 2003-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101181559B (en) | Preparation method of Chinese medicine preparation for curing fungi dermatosis | |
CN102319407B (en) | Traditional Chinese medicine for treating gastroptosis and extraction method thereof | |
CN1175440A (en) | Pill for cough, asthma and lung carbuncle | |
CN1131053C (en) | Chinese medicine for treating diabetes | |
CN1315457C (en) | Bath lotion for chilblain nursing and preparation method thereof | |
CN1181849C (en) | Gastropathy treating Chinese medicine | |
CN102205059A (en) | Chinese herbal medicine composition for treating liver cancer, stomach cancer, lung cancer and leukemia and preparation method thereof | |
CN101062213A (en) | Decoction of dried orange peel and pinellia Tuber | |
CN1056064C (en) | Medicine for curing liver cancer and its making method | |
CN1066391A (en) | The preparation method of medicine for bathe-" Yaowangshen yushenbao " | |
CN102327572A (en) | Chinese medicament for invigorating primordial energy and treating gastroptosis and extraction method thereof | |
CN1106257A (en) | Medicinal bag for preventing cough and asthma and its prodn. method | |
CN1113662C (en) | Compound red and yellow psoriasis capsule | |
CN1207879A (en) | Convalescence tea | |
CN1686227A (en) | Menstruation regulating powder | |
CN1320455A (en) | Capsule for treating gastroptosis | |
CN1055402C (en) | Shuangjie Jiangtangjing capsule | |
CN1058911A (en) | The compound method of capsule for curing tumour | |
CN100364605C (en) | Specific pellet for treating cold, and preparation method | |
CN1092984C (en) | Toad skin mixture for treating hepatitis B | |
CN1210724A (en) | Chinese herbal medicine powder for curing asthma | |
CN1223879A (en) | Stomach-benefiting powder | |
CN1144668A (en) | Ganshenning-medicine for hepato-renal | |
CN1559496A (en) | Chinese medicine preparation of removing obstruction in the channels for treating atrophic arthritis | |
CN1141780A (en) | Human-body purifying agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |